Stock listing

Champions Oncology, Inc.

Selected listing: A14X6S · LS · EUR · DE

Champions Oncology, Inc. (Lang & Schwarz: A14X6S), Health Technology. Latest release Sep 10, 2026: Champions Oncology Reports Revenue of $15.2 Million.

A14X6S:LSEURDEUpdated September 25, 2026

Ticker: Lang & Schwarz: A14X6S
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

About Champions Oncology, Inc.

Champions Oncology, Inc. (ticker: CSBR) is a public company based in the United States, specializing in oncology solutions. Champions Oncology leverages its proprietary technology to improve patient outcomes and support drug development.

Latest news from Champions Oncology, Inc.

Champions Oncology Reports Revenue of $15.2 Million

September 10, 2026

Champions Oncology Expands Integrated Radiopharmaceutical Development Platform with In-House SPECT/CT Imaging

September 1, 2026

Champions Oncology Reports Record Annual Revenue of $59 Million

July 27, 2026

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 27, 2026

July 20, 2026

Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy

March 29, 2026

All Champions Oncology, Inc. news →

Events

Replays

Champions Oncology, Inc. (CSBR) Q4 2026 Earnings Call
Mon, Jul 27, 2026 · 04:30 PM ET
Watch
Champions Oncology, Inc. (CSBR) Q3 2026 Earnings Call
Thu, Mar 12, 2026 · 04:30 PM ET
Watch
Champions Oncology, Inc. (CSBR) Q2 2026 Earnings Call
Mon, Dec 15, 2025 · 04:30 PM ET
Watch

Research Champions Oncology, Inc.

Champions Oncology, Inc. company profile

View the public company page for Champions Oncology, Inc. on 6ix.

Champions Oncology, Inc. news

Read company news and market updates connected to Champions Oncology, Inc..

Champions Oncology, Inc. investor events

Find investor webinars, events, and replay context for Champions Oncology, Inc..